BRÈVE

sur AFYREN (EPA:ALAFY)

AFYREN Signs Multi-Year Contract with US Nutraceutical Manufacturer

Graphique de l'évolution du cours de l'action AFYREN (EPA:ALAFY).

Clermont-Ferrand/Lyon, August 29, 2024 - AFYREN, a greentech company providing bio-based, low-carbon ingredients through unique fermentation technology, has finalized a commercial agreement with a US nutraceutical ingredients manufacturer.

The multi-year contract involves AFYREN supplying bio-based acids for use in preservatives and flavors for nutritional supplements. The nutraceuticals market, valued in the billions, is set for high-single-digit growth, driven by consumers' interest in natural and sustainable health products.

The US client, seeking alternatives to petro-based solutions, chose AFYREN for its natural fermentation process using traceable, non-food feedstock. The contract, initially based on limited volumes, may expand to larger quantities.

Nicolas Sordet, CEO of AFYREN, stated, “This contract demonstrates our ability to address specific markets with our unique value proposition, differentiating us from existing solutions.”

R. P.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de AFYREN